Skip to main content
James McCabe, MD, Cardiology, Seattle, WA, UW Medicine/University of Washington Medical Center

JamesMMcCabeMD, FACC, FAHA, FSCAI

Cardiology Seattle, WA

Interventional Cardiology

Section Chief Interventional Cardiology Professor of Medicine, University of Washington, David & Nancy Auth Endowed Chair of Cardiovascular Innovation

Dr. McCabe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. McCabe's full profile

Already have an account?

Summary

  • Board certified interventional cardiologist with a clinical practice focusing on transcatheter valve repair and replacement as well as other forms of complex structural heart disease and electrosurgery.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Interventional Cardiology, 2011 - 2013
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Cardiovascular Disease, 2008 - 2011
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2004 - 2007
  • Yale School of Medicine
    Yale School of MedicineClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2005 - Present
  • MT State Medical License
    MT State Medical License 2022 - 2026
  • OR State Medical License
    OR State Medical License 2019 - 2025
  • AK State Medical License
    AK State Medical License 2022 - 2024
  • WA State Medical License
    WA State Medical License 2013 - 2024
  • ID State Medical License
    ID State Medical License 2022 - 2024
  • GA State Medical License
    GA State Medical License 2021 - 2024
  • American Board of Internal Medicine Interventional Cardiology
  • American Registry for Diagnostic Medical Sonography (ARDMS)Register Physician in Vascular Interpretation (RPVI)
  • Join now to see all

Awards, Honors, & Recognition

  • Fellow (FAHA) American Heart Association
  • Finalist Thomas J. Linnemeier Award, 2014
  • Parmley Prize American College of Cardiology, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve  
    Brian Whisenant, Samir R Kapadia, Mackram F Eleid, James M Mccabe, Amar Krishnaswamy, Richard W Smalling, Charanjit S Rihal, Raj R Makkar, JAMA Cardiology
  • Coronary Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights from the OPEN-CTO Re...  
    David J Cohen, Sophia Airhart, J Aaron Grantham, Adam C Salisbury, James M McCabe, John A Spertus, ScienceDirect

Lectures

  • Brief Overview of Ultra Valve 
    CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
  • Options and Outcomes of Alternative Arterial Access: Carotid, Axillary, Subclavian, Transaortic 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
  • Managing Vascular Catastrophes After TAVR 
    CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
  • Join now to see all

Authored Content

  • One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020
  • One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020

Press Mentions

  • Cardiologists Make History, Becoming First to Use Fda-cleared Retrieval Device to Remove a Heart Tumor
    Cardiologists Make History, Becoming First to Use Fda-cleared Retrieval Device to Remove a Heart TumorAugust 18th, 2022
  • Different Assessment, Better Result for Heart Patient
    Different Assessment, Better Result for Heart PatientFebruary 3rd, 2020
  • FDA Expands TAVR Indication to Low-Risk Patients
    FDA Expands TAVR Indication to Low-Risk PatientsAugust 16th, 2019
  • Join now to see all

Committees

  • Chair, COAP PCI Analytics and Reporting Subcommittee 2014 - Present
  • Management Committee, Washington State Clinical Outcomes Assessment Program (COAP) 2013 - Present

Professional Memberships

Hospital Affiliations